1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Point-of-Care Glucose Testing Market, by Product
6.1. Introduction
6.2. Accu Check Aviva Meter
6.3. Accu-Chek Inform II
6.4. Bayer Contour Blood Glucose Monitoring System
6.5. Freestyle Lite
6.6. i-STAT
6.7. Onetouch Verio Flex
6.8. StatStrip
6.9. True Metrix

7. Point-of-Care Glucose Testing Market, by Mode of Purchase
7.1. Introduction
7.2. OTC Testing Product
7.3. Prescription-based Testing Product

8. Point-of-Care Glucose Testing Market, by End User
8.1. Introduction
8.2. Home Care Settings
8.3. Hospitals & Critical Care Centers
8.4. Outpatient & Ambulatory Care Facilities

9. California Point-of-Care Glucose Testing Market

10. Florida Point-of-Care Glucose Testing Market

11. Illinois Point-of-Care Glucose Testing Market

12. New York Point-of-Care Glucose Testing Market

13. Ohio Point-of-Care Glucose Testing Market

14. Pennsylvania Point-of-Care Glucose Testing Market

15. Texas Point-of-Care Glucose Testing Market

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Abbott Laboratories
17.2. Accubiotech Co. Ltd.
17.3. ACON Laboratories, Inc.
17.4. Becton, Dickinson, and Company
17.5. Bio-Rad Laboratories
17.6. bioLytical Laboratories Inc.
17.7. Chembio Diagnostics, Inc
17.8. Danaher Corporation
17.9. EKF Diagnostics
17.10. F. Hoffmann-La Roche Ltd.
17.11. Fluxergy
17.12. LifeScan, Inc. By Platinum Equity, LLC.
17.13. Medtronic PLC
17.14. Nipro Corporation
17.15. Nova Biomedical Corporation
17.16. OraSure Technologies Inc.
17.17. Prodigy Diabetes Care, LLC.
17.18. Quidel Corporation
17.19. Sekisui Diagnostics, LLC
17.20. Siemens Healthineers AG
17.21. Sinocare
17.22. Trinity Biotech PLC
17.23. Trividia Health, Inc.
17.24. Zoetis Inc.

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2020 VS 2027 (%)
FIGURE 4. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2027
FIGURE 6. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU CHECK AVIVA METER, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU CHECK AVIVA METER, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU-CHEK INFORM II, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU-CHEK INFORM II, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY BAYER CONTOUR BLOOD GLUCOSE MONITORING SYSTEM, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY BAYER CONTOUR BLOOD GLUCOSE MONITORING SYSTEM, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY FREESTYLE LITE, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY FREESTYLE LITE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 14. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY I-STAT, 2018-2027 (USD MILLION)
FIGURE 15. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY I-STAT, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 16. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONETOUCH VERIO FLEX, 2018-2027 (USD MILLION)
FIGURE 17. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONETOUCH VERIO FLEX, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 18. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATSTRIP, 2018-2027 (USD MILLION)
FIGURE 19. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATSTRIP, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 20. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TRUE METRIX, 2018-2027 (USD MILLION)
FIGURE 21. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TRUE METRIX, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 22. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2020 VS 2027 (%)
FIGURE 23. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2020 VS 2027 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2027
FIGURE 25. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OTC TESTING PRODUCT, 2018-2027 (USD MILLION)
FIGURE 26. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OTC TESTING PRODUCT, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRESCRIPTION-BASED TESTING PRODUCT, 2018-2027 (USD MILLION)
FIGURE 28. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRESCRIPTION-BASED TESTING PRODUCT, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 29. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2020 VS 2027 (%)
FIGURE 30. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2020 VS 2027 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2027
FIGURE 32. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE SETTINGS, 2018-2027 (USD MILLION)
FIGURE 33. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE SETTINGS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 34. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CRITICAL CARE CENTERS, 2018-2027 (USD MILLION)
FIGURE 35. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CRITICAL CARE CENTERS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 36. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OUTPATIENT & AMBULATORY CARE FACILITIES, 2018-2027 (USD MILLION)
FIGURE 37. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OUTPATIENT & AMBULATORY CARE FACILITIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 38. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET: FPNV POSITIONING MATRIX
FIGURE 39. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 40. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU CHECK AVIVA METER, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU-CHEK INFORM II, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY BAYER CONTOUR BLOOD GLUCOSE MONITORING SYSTEM, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY FREESTYLE LITE, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY I-STAT, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONETOUCH VERIO FLEX, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATSTRIP, BY STATE, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TRUE METRIX, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OTC TESTING PRODUCT, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRESCRIPTION-BASED TESTING PRODUCT, BY STATE, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE SETTINGS, BY STATE, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CRITICAL CARE CENTERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OUTPATIENT & AMBULATORY CARE FACILITIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET: SCORES
TABLE 20. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET: BUSINESS STRATEGY
TABLE 21. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET: PRODUCT SATISFACTION
TABLE 22. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET: RANKING
TABLE 23. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 24. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET: MERGER & ACQUISITION
TABLE 25. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 26. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 27. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET: INVESTMENT & FUNDING
TABLE 28. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 29. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET: LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Accubiotech Co. Ltd.
ACON Laboratories, Inc.
Becton, Dickinson, and Company
Bio-Rad Laboratories
bioLytical Laboratories Inc.
Chembio Diagnostics, Inc
Danaher Corporation
EKF Diagnostics
F. Hoffmann-La Roche Ltd.
Fluxergy
LifeScan, Inc. By Platinum Equity, LLC.
Medtronic PLC
Nipro Corporation
Nova Biomedical Corporation
OraSure Technologies Inc.
Prodigy Diabetes Care, LLC.
Quidel Corporation
Sekisui Diagnostics, LLC
Siemens Healthineers AG
Sinocare
Trinity Biotech PLC
Trividia Health, Inc.
Zoetis Inc.